Homeostatic Signaling by Cell–Cell Junctions and Its Dysregulation during Cancer Progression

Por Yu, Yang, Elble, Randolph C.
Publicado no J Clin Med (2016)

Loss of CLCA4 Promotes Epithelial-to-Mesenchymal Transition in Breast Cancer Cells

Por Yu, Yang, Walia, Vijay, Elble, Randolph C.
Publicado em 2013

Tet-On lentiviral transductants lose inducibility when silenced for extended intervals in mammary epithelial cells

Por Yu, Yang, Lowy, Michelle Montag, Elble, Randolph C.
Publicado no Metab Eng Commun (2016)

CLCA2 Interactor EVA1 Is Required for Mammary Epithelial Cell Differentiation

Por Ramena, Grace, Yin, Yufang, Yu, Yang, Walia, Vijay, Elble, Randolph C.
Publicado no PLoS One (2016)

hCLCA2 is a p53-inducible inhibitor of breast cancer cell proliferation

Por Walia, Vijay, Ding, Ming, Kumar, Sumit, Nie, Daotai, Premkumar, Louis, Elble, Randolph C.
Publicado em 2009

p53 represses c-Myc through induction of the tumor suppressor miR-145

Por Sachdeva, Mohit, Zhu, Shoumin, Wu, Fangting, Wu, Hailong, Walia, Vijay, Kumar, Sumit, Elble, Randolph, Watabe, Kounosuke, Mo, Yin-Yuan
Publicado em 2009

mCLCA4 ER processing and secretion requires luminal sorting motifs

Por Huan, Chunlei, Greene, Kai Su, Shui, Bo, Spizz, Gwendolyn, Sun, Haitao, Doran, Robert M., Fisher, Patricia J., Roberson, Mark S., Elble, Randolph C., Kotlikoff, Michael I.
Publicado em 2008

Loss of breast epithelial marker hCLCA2 promotes epithelial to mesenchymal transition and indicates higher risk of metastasis

Por Walia, Vijay, Yu, Yang, Cao, Deshou, Sun, Miao, McLean, Janel R., Hollier, Brett G., Cheng, Jiming, Mani, Sendurai A., Rao, Krishna, Premkumar, Louis, Elble, Randolph
Publicado em 2011

Mutational and Functional Analysis of the Tumor-Suppressor PTPRD in Human Melanoma

Por Walia, Vijay, Prickett, Todd D., Kim, Jung-Sik, Gartner, Jared J., Lin, Jimmy C., Zhou, Ming, Rosenberg, Steven A., Elble, Randolph C., Solomon, David A., Waldman, Todd, Samuels, Yardena
Publicado no Hum Mutat (2014)